Alzheimer’s disease (AD) is characterized by synapse loss and neuronal degeneration, progressive cognitive decline in older individuals, and the accumulation of aggregates of beta amyloid (Aβ) and hyperphosphorylated tau in the brains [1]. Here, MAPT is linked to Alzheimer disease.